Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
ABVD
OpenAlex ID:
C2776305933
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
1992
·
George P. Canellos
, James R. Anderson
, et al.
·
New England Journal of Medicine
·
1,177
PDF
Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
2003
·
Volker Diehl
, Jeremy Franklin
, et al.
·
New England Journal of Medicine
·
899
PDF
Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
2007
·
Andrea Gallamini
, Martin Hutchings
, et al.
·
Journal of Clinical Oncology
·
890
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
2017
·
Joseph M. Connors
, Wojciech Jurczak
, et al.
·
New England Journal of Medicine
·
871
PDF
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
2015
·
John Radford
, Tim Illidge
, et al.
·
New England Journal of Medicine
·
819
PDF
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
1975
·
Gianni Bonadonna
, Roberto Zucali
, et al.
·
Cancer
·
780
PDF
Hodgkin lymphoma: A review and update on recent progress
2017
·
Satish Shanbhag
, Richard F. Ambinder
·
CA A Cancer Journal for Clinicians
·
595
PDF
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
2009
·
Andreas Engert
, Volker Diehl
, et al.
·
Journal of Clinical Oncology
·
533
Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial
2003
·
David B. Duggan
, Gina R. Petroni
, et al.
·
Journal of Clinical Oncology
·
511
Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group
2003
·
Andreas Engert
, Petra Schiller
, et al.
·
Journal of Clinical Oncology
·
487
Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study
2007
·
Anthony J. Swerdlow
, Craig D. Higgins
, et al.
·
JNCI Journal of the National Cancer Institute
·
481
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
2010
·
Hans Theodor Eich
, Volker Diehl
, et al.
·
Journal of Clinical Oncology
·
468
PDF
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
2011
·
Simonetta Viviani
, Pier Luigi Zinzani
, et al.
·
New England Journal of Medicine
·
441
PDF
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
2011
·
Ralph M. Meyer
, Mary K. Gospodarowicz
, et al.
·
New England Journal of Medicine
·
431
PDF
Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
2014
·
John M.M. Raemaekers
, Marc P.E. André
, et al.
·
Journal of Clinical Oncology
·
405
PDF
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
1987
·
A Santoro
, G Bonadonna
, et al.
·
Journal of Clinical Oncology
·
385
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD
1985
·
S. Viviani
, A. Santoro
, et al.
·
European Journal of Cancer and Clinical Oncology
·
379
Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease: A Report of 8-Year Results
1986
·
GIANNI BONADONNA
, PINUCCIA VALAGUSSA
, et al.
·
Annals of Internal Medicine
·
373
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
2010
·
Sally F. Barrington
, Wendi Qian
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
365
ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results
2004
·
Gianni Bonadonna
, Valeria Bonfante
, et al.
·
Journal of Clinical Oncology
·
354
PDF
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
2012
·
Bastian von Tresckow
, Annette Plütschow
, et al.
·
Journal of Clinical Oncology
·
345
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
2005
·
Ralph M. Meyer
, Mary K. Gospodarowicz
, et al.
·
Journal of Clinical Oncology
·
336
PDF
Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
2005
·
Karolin Behringer
, Kai Breuer
, et al.
·
Journal of Clinical Oncology
·
332
Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
2012
·
Leo I. Gordon
, Fangxin Hong
, et al.
·
Journal of Clinical Oncology
·
331
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
2013
·
Alberto Biggi
, Andrea Gallamini
, et al.
·
Journal of Nuclear Medicine
·
324
PDF
Show more works
View as search
Works count:
2,817
Citation count:
55,940
Year
Topic
Type